Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open, Sequential Dose-Escalation, Single-Center, Phase 1 Clinical Trial to Evaluate Tolerability, Safety, and Exploratory Efficacy of ATORM-C in Patients With Crohn's Disease

NCT07822087 is registered in ClinicalTrials.gov with ORGANOIDSCIENCES LTD. as lead sponsor.

NCT NCT07822087
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07822087 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open, Sequential Dose-Escalation, Single-Center, Phase 1 Clinical Trial to Evaluate Tolerability, Safety, and Exploratory Efficacy of ATORM-C in Patients With Crohn's Disease
Lead sponsor
ORGANOIDSCIENCES LTD.
Phase
Phase 1
Overall status
Recruiting
Start date
September 30, 2026
Completion date
August 31, 2028
Enrollment
18 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

crohn's disease, crohn's diseases